Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2026-02-22 @ 6:45 PM
Study NCT ID:
NCT03695250
Status:
TERMINATED
Last Update Posted:
2023-08-22
First Post:
2018-10-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer
Sponsor:
Edward Kim
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
1229924
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None